Klin Onkol 2003; 16(1): 10-18.
Summary: The advances in therapeutic outcome of the head and neck carcinoma derived from integration of new systemic cytotoxic agents and radiosensitizers into various combined modality apporaches. Recently neoadjuvant setting for locally advanced head and neck carcinoma have been extensively investigated with promising results. Participating in clinical trials is especially encouraged.
